Cargando…
Myocardial injury in a patient with severe coronavirus disease: A case report()
INTRODUCTION: Coronavirus disease (COVID-19) can lead to severe disease or death and is characterized by a wide range of mild to severe symptoms. In addition to the lungs, studies have reported the involvement of the stomach, intestine, and angiotensin-converting enzyme 2 receptors in the heart. CAS...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538152/ https://www.ncbi.nlm.nih.gov/pubmed/33036894 http://dx.doi.org/10.1016/j.jiac.2020.09.023 |
_version_ | 1783590810343702528 |
---|---|
author | Nakamura, Yuki Shimizu, Masaru Yamaki, Taeka Kushimoto, Kohsuke Yamashita, Ayahiro Hayase, Kazuma Yamazaki, Masaki Hashimoto, Satoru Ohta, Bon |
author_facet | Nakamura, Yuki Shimizu, Masaru Yamaki, Taeka Kushimoto, Kohsuke Yamashita, Ayahiro Hayase, Kazuma Yamazaki, Masaki Hashimoto, Satoru Ohta, Bon |
author_sort | Nakamura, Yuki |
collection | PubMed |
description | INTRODUCTION: Coronavirus disease (COVID-19) can lead to severe disease or death and is characterized by a wide range of mild to severe symptoms. In addition to the lungs, studies have reported the involvement of the stomach, intestine, and angiotensin-converting enzyme 2 receptors in the heart. CASE REPORT: We present a case of a patient with COVID-19 who died soon after developing multi-organ failure and myocardial injury due to COVID-19-associated pneumonia. A 71-year-old man who contracted COVID-19 was admitted to the hospital after presenting with fever for 7 days and developed dyspnea. Following treatment, his respiratory status worsened. Thus, he was transferred to our hospital for intensive care on day 11. Physical examination revealed fever, dyspnea, respiratory distress, and no chest pain. Invasive positive pressure ventilation was initiated for acute respiratory distress syndrome on day 14. On day 15, we observed renal, liver, and coagulation dysfunction, indicating multi-organ failure. Chest radiography did not show clear signs of an increased cardiothoracic ratio or pulmonary congestion. An electrocardiogram (ECG) showed signs of myocardial infarction, which was confirmed by elevated troponin I and creatine kinase levels. The patient's circulatory dynamics did not improve on medication, and he died on day 16. CONCLUSIONS: We report the case of a patient with severe COVID-19 who died from an exacerbation of myocardial injury. Clinicians should not only evaluate respiration but also assess the heart by performing a 12-lead ECG, echocardiogram, and myocardial injury marker examination. Together, these tools can help predict which patients will develop severe COVID-19. |
format | Online Article Text |
id | pubmed-7538152 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75381522020-10-07 Myocardial injury in a patient with severe coronavirus disease: A case report() Nakamura, Yuki Shimizu, Masaru Yamaki, Taeka Kushimoto, Kohsuke Yamashita, Ayahiro Hayase, Kazuma Yamazaki, Masaki Hashimoto, Satoru Ohta, Bon J Infect Chemother Case Report INTRODUCTION: Coronavirus disease (COVID-19) can lead to severe disease or death and is characterized by a wide range of mild to severe symptoms. In addition to the lungs, studies have reported the involvement of the stomach, intestine, and angiotensin-converting enzyme 2 receptors in the heart. CASE REPORT: We present a case of a patient with COVID-19 who died soon after developing multi-organ failure and myocardial injury due to COVID-19-associated pneumonia. A 71-year-old man who contracted COVID-19 was admitted to the hospital after presenting with fever for 7 days and developed dyspnea. Following treatment, his respiratory status worsened. Thus, he was transferred to our hospital for intensive care on day 11. Physical examination revealed fever, dyspnea, respiratory distress, and no chest pain. Invasive positive pressure ventilation was initiated for acute respiratory distress syndrome on day 14. On day 15, we observed renal, liver, and coagulation dysfunction, indicating multi-organ failure. Chest radiography did not show clear signs of an increased cardiothoracic ratio or pulmonary congestion. An electrocardiogram (ECG) showed signs of myocardial infarction, which was confirmed by elevated troponin I and creatine kinase levels. The patient's circulatory dynamics did not improve on medication, and he died on day 16. CONCLUSIONS: We report the case of a patient with severe COVID-19 who died from an exacerbation of myocardial injury. Clinicians should not only evaluate respiration but also assess the heart by performing a 12-lead ECG, echocardiogram, and myocardial injury marker examination. Together, these tools can help predict which patients will develop severe COVID-19. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021-02 2020-10-06 /pmc/articles/PMC7538152/ /pubmed/33036894 http://dx.doi.org/10.1016/j.jiac.2020.09.023 Text en © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Case Report Nakamura, Yuki Shimizu, Masaru Yamaki, Taeka Kushimoto, Kohsuke Yamashita, Ayahiro Hayase, Kazuma Yamazaki, Masaki Hashimoto, Satoru Ohta, Bon Myocardial injury in a patient with severe coronavirus disease: A case report() |
title | Myocardial injury in a patient with severe coronavirus disease: A case report() |
title_full | Myocardial injury in a patient with severe coronavirus disease: A case report() |
title_fullStr | Myocardial injury in a patient with severe coronavirus disease: A case report() |
title_full_unstemmed | Myocardial injury in a patient with severe coronavirus disease: A case report() |
title_short | Myocardial injury in a patient with severe coronavirus disease: A case report() |
title_sort | myocardial injury in a patient with severe coronavirus disease: a case report() |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538152/ https://www.ncbi.nlm.nih.gov/pubmed/33036894 http://dx.doi.org/10.1016/j.jiac.2020.09.023 |
work_keys_str_mv | AT nakamurayuki myocardialinjuryinapatientwithseverecoronavirusdiseaseacasereport AT shimizumasaru myocardialinjuryinapatientwithseverecoronavirusdiseaseacasereport AT yamakitaeka myocardialinjuryinapatientwithseverecoronavirusdiseaseacasereport AT kushimotokohsuke myocardialinjuryinapatientwithseverecoronavirusdiseaseacasereport AT yamashitaayahiro myocardialinjuryinapatientwithseverecoronavirusdiseaseacasereport AT hayasekazuma myocardialinjuryinapatientwithseverecoronavirusdiseaseacasereport AT yamazakimasaki myocardialinjuryinapatientwithseverecoronavirusdiseaseacasereport AT hashimotosatoru myocardialinjuryinapatientwithseverecoronavirusdiseaseacasereport AT ohtabon myocardialinjuryinapatientwithseverecoronavirusdiseaseacasereport |